Enhanced Genomics

To add a bio or update company history, please click update information.

News from Enhanced Genomics

Enhanced Genomics raises £14m Series A from investors to advance therapeutics pipeline with its 3D multi-omics platform

16 Sept 2025

Enhanced Genomics raises £14m Series A from investors to advance therapeutics pipeline with its 3D multi-omics platform

Enhanced Genomics uses a three-dimensional multi-omics platform to identify genetically validated drug targets, supporting the development of new medicines for complex common diseases.

Enhanced Genomics

Life Sciences
Cambridge, United Kingdom
£14m
enhancedgenomics.com
Update Information

More venture news

Semarion
31 Mar 2026
Semarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery
EquityLife Sciences
Sequential Bio
17 Mar 2026
Sequential secures £2.6m in funding led by Sparkfood and Corundum Systems Biology for non-invasive testing of skin health ingredients
EquityLife Sciences
Mestag Therapeutics
16 Mar 2026
Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies
EquityLife Sciences

Enhanced Genomics

News from Enhanced Genomics

Enhanced Genomics raises £14m Series A from investors to advance therapeutics pipeline with its 3D multi-omics platform

More venture news

Semarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery

Sequential secures £2.6m in funding led by Sparkfood and Corundum Systems Biology for non-invasive testing of skin health ingredients

Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies